Clinical Trial Update: Does Semaglutide Reduce Alcohol Intake in Patients With Alcohol Use Disorder and Comorbid Obesity? [Phase 2]

View source ↗

Summary

Phase 2 trial status update examining whether semaglutide reduces alcohol intake in patients with alcohol use disorder and obesity.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Use Disorder
• Obesity

Drugs mentioned

• semaglutide (semaglutide)

Snippet

Sponsor: Psychiatric Centre Rigshospitalet | Conditions: Alcohol Abuse, Alcohol Addiction | Phase 2 | Status: COMPLETED